Human papillomavirus oncoproteins induce a reorganization of epithelial-associated γδ T cells promoting tumor formation

Proceedings of the National Academy of Sciences of the United States of America
Dorien Van HedeNathalie Jacobs

Abstract

It has been shown that γδ T cells protect against the formation of squamous cell carcinoma (SCC) in several models. However, the role of γδ T cells in human papillomavirus (HPV)-associated uterine cervical SCC, the third-leading cause of death by cancer in women, is unknown. Here, we investigated the impact of γδ T cells in a transgenic mouse model of carcinogenesis induced by HPV16 oncoproteins. Surprisingly, γδ T cells promoted the development of HPV16 oncoprotein-induced lesions. HPV16 oncoproteins induced a decrease in epidermal Skint1 expression and the associated antitumor Vγ5+ γδ T cells, which were replaced by γδ T-cell subsets (mainly Vγ6+ γδlowCCR2+CCR6-) actively producing IL-17A. Consistent with a proangiogenic role, γδ T cells promoted the formation of blood vessels in the dermis underlying the HPV-induced lesions. In human cervical biopsies, IL-17A+ γδ T cells could only be observed at the cancer stage (SCC), where HPV oncoproteins are highly expressed, supporting the clinical relevance of our observations in mice. Overall, our results suggest that HPV16 oncoproteins induce a reorganization of the local epithelial-associated γδ T-cell subpopulations, thereby promoting angiogenesis and cancer development.

References

Jun 1, 1975·Gynecologic Oncology·G Delgado, J P Smith
Sep 22, 2001·Science·M GirardiA C Hayday
Apr 27, 2002·Science·Julie JamesonWendy L Havran
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Nov 2, 2002·Blood·Muneo NumasakiMichael T Lotze
Apr 16, 2003·The Journal of Experimental Medicine·Dylan DanielDouglas Hanahan
Aug 6, 2003·The Journal of Experimental Medicine·Yunfei GaoZhinan Yin
Oct 4, 2003·Journal of Leukocyte Biology·Christina L RoarkRebecca L O'Brien
Mar 10, 2004·The Journal of Experimental Medicine·Shayna E A StreetMark J Smyth
Apr 30, 2005·Immunology Letters·Hidenori TakahashiHidetada Sasaki
May 31, 2007·The Journal of Experimental Medicine·Georg StaryGeorg Stingl
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sigrun ResslerWerner Zwerschke
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhiyong LiuRichard D Lopez
Mar 17, 2010·International Journal of Cancer. Journal International Du Cancer·Anne MassetAgnès Noël
Apr 17, 2010·European Journal of Immunology·Daiko WakitaTakashi Nishimura
Jun 5, 2010·PLoS Pathogens·Rabinarayan MishraEva Szomolanyi-Tsuda
Jul 2, 2010·Nature Reviews. Cancer·Cary A Moody, Laimonis A Laimins
Feb 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Susannah D BarbeeAdrian C Hayday
Feb 23, 2011·The Journal of Experimental Medicine·Nital SumariaWolfgang Weninger
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Mar 9, 2011·The Journal of Experimental Medicine·Yuting MaLaurence Zitvogel
May 4, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elizabeth E GrayJason G Cyster
Aug 5, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ute LaggnerFrank O Nestle
Feb 14, 2012·Nature Immunology·Grzegorz ChodaczekTomasz Zal
May 29, 2012·Immunity·Albert Zlotnik, Osamu Yoshie
Aug 17, 2012·The Journal of Investigative Dermatology·Tomotaka MabuchiSam T Hwang
Jan 26, 2013·Nature Reviews. Immunology·Pierre Vantourout, Adrian Hayday
May 21, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Telma LançaBruno Silva-Santos
Jan 7, 2014·Annual Review of Immunology·Yueh-hsiu ChienMarc Bonneville
Mar 25, 2014·Annual Review of Immunology·Jason W GriffithAndrew D Luster
Jul 27, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christina GosmannAntje Blumenthal
Aug 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Margarida ReiBruno Silva-Santos
Oct 28, 2014·Frontiers in Immunology·David Vermijlen, Immo Prinz

❮ Previous
Next ❯

Citations

Jul 24, 2020·Immunological Reviews·Rebecca L O'Brien, Willi K Born
Aug 26, 2020·Immunological Reviews·Toshiyasu SuzukiSeth B Coffelt
Jul 10, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adrian C Hayday
Oct 19, 2019·Clinical & Translational Immunology·Mathilde RaverdeauLydia Lynch
Apr 27, 2019·International Journal of Molecular Sciences·Matthew J BottomleyIrene Leigh
Jun 19, 2019·Nature Reviews. Cancer·Bruno Silva-SantosSeth B Coffelt
Jul 2, 2020·Cells·Ling MaDavid Vermijlen
Jul 24, 2020·Cellular & Molecular Immunology·Dieter KabelitzShirin Kalyan
May 8, 2018·Frontiers in Immunology·Duncan R McKenzieShaun R McColl
Nov 15, 2020·European Journal of Immunology·Noëlla Lopes, Bruno Silva-Santos
Mar 6, 2021·Frontiers in Immunology·Yang LiXi Chen
May 4, 2021·Immunologic Research·Christian SelingerSamuel Alizon
Jul 25, 2021·Cancers·Emilie BarsacChristophe Paget
Jul 6, 2021·European Journal of Immunology·Rasmus Agerholm, Vasileios Bekiaris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.